Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Maine PFAS advisory committee divided on whether PFAS Fund should cover LD 582 fiscal note
Summary
Committee members debated LD 582, a bill requiring insurers to cover PFAS blood testing; legislators and staff said the bill's $90,000 FY27 fiscal note rises in later years, and committee members asked for legal and fiscal analysis before recommending the Fund cover the cost.
Members of Maine’s PFAS Advisory Committee on Dec. 15 split over whether the PFAS Fund should be used to pay the fiscal note for LD 582, legislation that would require health insurers to cover PFAS blood‑serum testing.
Representative Dan Ancoli, co‑chair of the advisory committee, framed the fiscal concern: "This fund does not have a sustainable funding source. It had it has what it has, and, we have to factor that in when we talk about mandating coverage," he said, arguing that the Fund was created for agricultural impacts and might run out if used for an ongoing statewide mandate.
Director Beth Valentine reviewed the bill’s scope and legal context and said the statute establishing the PFAS Fund ties Fund uses to people exposed through…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
